Incyte Says FDA Extended Review Period for Opzelura

• click to rate

  Posted by Two Blokes Jun 20 - Filed in Stock - 6 views
  
  Incyte said federal regulators have extended the review period for evaluating its Opzelura cream as a treatment for moderate atopic dermatitis in children aged 2 to 11.